Skip to content
Answers from the Lab cover art

All episodes

Answers from the Lab, 392 episodes. Page 3 of 4.

#
Title
201

Ensuring quality in the lab: Dr. Bill Morice

202

Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.

203

Staying safe during the holidays: Dr. Bill Morice

204

Carrier Screening: Linda Hasadsri, M.D., Ph.D.

205

The challenges facing most health care leaders: Dr. Bill Morice

206

Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.

207

Legislation, leadership, and MayoComplete: Dr. Bill Morice

208

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

209

Testing is essential in the months ahead: Dr. Bill Morice

210

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

211

Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.

212

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

213

Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.

214

Preparing for respiratory infection season: Dr. Matthew Binnicker

215

Chain of Custody Testing: Loralie Langman, Ph.D.

216

Shifting from pandemic to endemic: Dr. Bill Morice

217

Virus outlook heading into fall: Dr. Bill Morice

218

Advocating for lab legislation: Dr. Bill Morice

219

PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.

220

Leading diagnostics into the future: Dr. Bill Morice

221

PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.

222

PETH: Paul Jannetto, Ph.D.

223

Looking at the big picture: Dr. Bill Morice

224

Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.

225

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

226

Monkeypox and legislation updates: Dr. Bill Morice

227

CIDP: Divyanshu (Div) Dubey, M.B.B.S.

228

Ongoing evolution of monkeypox: Dr. Bill Morice

229

PMND1: John Lieske, M.D.

230

Monkeypox testing progress: Dr. Bill Morice

231

Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.

232

Operationalizing monkeypox testing: John Osborn

233

Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.

234

Monkeypox declared a global public health emergency: Dr. Bill Morice

235

FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.

236

Managing the current rise in COVID cases: Dr. Bill Morice

237

Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice

238

New SALSA bill and monkeypox testing at Mayo: Dr. Bill Morice

239

The Latest on Monkeypox and Lab Legislation: Dr. Bill Morice

240

The age of pandemics: Dr. Bill Morice

241

WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC

242

Monkeypox: Dr. Bill Morice

243

Being Mindful of Mental Health: John Black, M.D.

244

Viruses and variants: Dr. Bill Morice

245

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

246

VALID Act: Dr. Bill Morice

247

Tick-borne Disease Testing: Elitza Theel, Ph.D.

248

Lab Legislation Update: Dr. Bill Morice

249

NFLC: Alicia Algeciras, Ph.D.

250

Lab Medicine’s Role in the Clinical Practice: Dr. Bill Morice

251

ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.

252

Regulation of Lab Developed Tests: Dr. Bill Morice

253

Advancements in autoimmune neurology: Dr. Andrew McKeon

254

COVID-19 Update: Dr. Bill Morice

255

IBDP2: Melissa Snyder, Ph.D.

256

CLIA-Licensed Laboratories: Dr. Bill Morice

257

Chromium and Cobalt: Paul Jannetto, Ph.D.

258

Laboratory Innovation: Dr. Bill Morice

259

TPNUQ: Ann Moyer, M.D., Ph.D.

260

Lab developed tests: Dr. Bill Morice

261

MSP3: Maria Alice Willrich, Ph.D.

262

New COVID-19 variants: Dr. Bill Morice

263

Oversight of the laboratory industry: Dr. Bill Morice

264

Urinary ammonium testing: John Lieske, M.D.

265

New Strategies to Combat COVID-19: Dr. Bill Morice

266

New Masking Guidelines: Dr. Bill Morice

267

Extended spectrum beta lactamase testing: Audrey Schuetz, M.D.

268

Informatics and Laboratory Medicine: Dr. David McClintock

269

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

270

Adapting as COVID-19 Changes: Dr. Bill Morice

271

Interpreting Lab Test Results: Dr. Bill Morice

272

Tackling COVID-19 Misinformation: Dr. Bill Morice

273

A Global Perspective on COVID-19: Dr. Bill Morice

274

COVID-19 Antigen Tests: Dr. Bill Morice

275

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

276

Respiratory Virus Testing: Dr. Matthew Binnicker

277

Omicron Update: Dr. Bill Morice

278

Reflections on how far we’ve come: Dr. Bill Morice

279

Autoimmune Axonal Testing: Divyanshu (Div) Dubey, M.B.B.S.

280

At-Home COVID-19 Tests: Dr. Brad Karon

281

Holiday Safety and COVID-19: Dr. Bill Morice

282

The State of COVID-19 Now: Dr. Bill Morice

283

Omicron Variant: Dr. Bill Morice

284

CYPZ: Michelle Kluge, M.S., CGC

285

Lab-Developed Tests: Shannon Bennett

286

Hereditary Oncology Testing: Wei Shen, Ph.D.

287

COVID-19 Antibody Testing: Dr. Elitza Theel

288

IDENT: Audrey Schuetz, M.D.

289

COVID-19, Moving Forward: Dr. Bill Morice

290

The State of COVID-19 Today: Dr. Bill Morice

291

The Global Impact of COVID-19: Dr. Bill Morice

292

NF155: John Mills, Ph.D.

293

How AI is Shaping the Future of Laboratory Medicine: Dr. Bill Morice

294

Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

295

The Value of a Flu Vaccine Amid COVID-19: Dr. Bill Morice

296

T-cell Lymphoma Testing: Dr. Andrew Feldman

297

COVID-19 National Strategy: Dr. Bill Morice

298

PGXQP: Ann Moyer, M.D., Ph.D.

299

COVID-19 Vaccine Myths: Dr. Bill Morice & Dr. Matt Binnicker

300

COVID-19 Vaccine Boosters: Dr. Bill Morice